Close Menu
July 29, 2020
Sponsored by

Life Science Marketing Workshop: Creating a Go-To-Market Strategy in a Rapidly Evolving Sector


“If we build it, they will come” is a familiar refrain that echoes in life science entrepreneurial circles. Too frequently startups believe that if a technology is built it will sell. But the chasm that exists between a great technology and an executable go-to-market strategy is large. This webinar will break down the steps to build a branding and marketing approach needed to precede a new product rollout in the life science marketplace.

Will Gould, President and CSO of Brand Buddha, will break down the process of message development, audience segmentation, and how to target the right person, with the right message, in the right place, at the right time. Deb Franko, Principal of boutique healthcare marketing communications agency Karmic Health Communications, will provide insight into how to raise consumer awareness and drive patient adoption of new oncology solutions.

Together they will discuss how to develop a go-to-market strategy mapping all touchpoints from pre-awareness through to completed sale.

In this webinar you will learn:

  • How to find your audience and potential clients
  • How to develop branding and messaging that will resonate with your audience
  • How to put that message in front of your audience and the right time and in the right place
  • How to graduate your audience from pre-awareness to converted client
Sponsored by

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.

Sponsored by
10x Genomics

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease characterized by irreversible scarring of the distal lung, leading to respiratory failure. 

Sponsored by

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Sponsored by

This webinar will outline the use of targeted protein degradation (TPD) to understand transcriptional processes at a high kinetic resolution.

Sponsored by

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.